Published in
Springer, Breast Cancer Research and Treatment, 3(165), p. 601-609, 2017
DOI: 10.1007/s10549-017-4375-5
Links
Tools
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer
Journal article published in 2017 by
Hope S. Rugo 
,
Olivier Trédan,
Jungsil Ro,
Serafin M. Morales ,
Mario Campone,
Antonino Musolino ,
Noémia Afonso,
Marta Ferreira,
Kyong Hwa Park,
Javier Cortes,
Antoinette R. Tan,
Joanne L. Blum,
Lamar Eaton,
Christine K. Gause,
Zhen Wang
and other authors.
,
Olivier Trédan,
Jungsil Ro,
Serafin M. Morales ,
Mario Campone,
Antonino Musolino ,
Noémia Afonso,
Marta Ferreira,
Kyong Hwa Park,
Javier Cortes,
Antoinette R. Tan,
Joanne L. Blum,
Lamar Eaton,
Christine K. Gause,
Zhen Wang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 